Search

everythinglearnresearchcommunity

for

Search:↓

Bupropion causes more hair loss than other antidepressants, with paroxetine causing the least.

Clomipramine alone does not reduce overgrooming in cats with psychogenic alopecia.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Low iron and vitamin D levels are linked to hair loss in women.

About 15% of adolescent girls in a region of India have Polycystic Ovarian Syndrome, which is more common in those born by cesarean, with wisdom teeth, or with central obesity.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Oral dutasteride works better for hair loss, but has more sexual side effects; intralesional dutasteride is a possible alternative.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Lower SHBG levels may increase the risk of PCOS.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

The document concludes that PK/PD modeling is important for determining the safe and effective dosages of drugs.

Stem cell therapy helps heal burn wounds, especially second-degree burns, by promoting blood vessel growth and reducing inflammation.

Hair characteristics might be early signs of Type 2 Diabetes and could help with early prevention.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Isotretinoin is effective for treating dissecting cellulitis, but recurrence is common.

PRP improves hair thickness for both genders, but only increases hair density in men.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Women with irregular periods have a higher risk of heart disease.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

The letter suggests that a modified fat processing technique may increase regenerative cells but calls for more trials to confirm its effectiveness for skin and hair treatments.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

30% supramolecular salicylic acid is safe and effective for treating mild to moderate facial acne.